In other countries
The same active substances on other registers, the same brand first.
- TalveyBrazil · Janssen-Cilag Farmacêutica LtdaSame brand
- Talvey 2 MG/ML Solucion InyectableSpain · 3 mg · solución inyectable · Janssen-Cilag International N.VSame brand
- Talvey 40 MG/ML Solucion InyectableSpain · 40 mg · solución inyectable · Janssen-Cilag International N.VSame brand
- TalveyEuropean Union · Janssen-Cilag International N.V.Same brand
- TalveyCroatiaSame brand
- TalveyItaly · Soluzione iniettabile · Janssen-Cilag International N.V.Same brand
- TALVEY 2 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Janssen-Cilag International NVSame brand
- TALVEY 40 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Janssen-Cilag International NVSame brand
- Talvey Solution for Injection 40MG/MLSingapore · 40mg/mL · injection, solution · Johnson & Johnson International (Singapore) Pte LTDSame brand
- Talvey Solution for Injection 3MG/1.5MLSingapore · 3mg/1.5mL · injection, solution · Johnson & Johnson International (Singapore) Pte LTDSame brand
- Talvey Solution for Injection 2 mg/mLTaiwan · 注射液劑 · 嬌生股份有限公司Same brand
- Talvey Solution for Injection 40 mg/mLTaiwan · 注射液劑 · 嬌生股份有限公司Same brand
- TalveyUnited States · 3MG/1.5ML, 40MG/ML · injectable · Janssen BiotechSame brand
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Talquetamab
- Strength
- 2 MG / ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 4 Mar 2025
- Registration
- DIN 02547392
- Marketing authorisation holder
- Janssen INC
- ATC code
- L01FX29
- Supply
- PRESCRIPTION, SCHEDULE D